Tc-99m-MIBI scintigraphy in metastatic renal cell carcinoma: Clinical validation of the relationship between Tc-99m-MIBI uptake and P-glycoprotein expression in tumour tissue
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, vol.23, no.8, pp.976-979, 1996 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 23 Issue: 8
- Publication Date: 1996
- Doi Number: 10.1007/bf01084374
- Journal Name: EUROPEAN JOURNAL OF NUCLEAR MEDICINE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
- Page Numbers: pp.976-979
- Keywords: technetium-99m, hexakis-2-methoxyisobutylisonitrile, P-glycoprotein, renal cell carcinoma, multidrug resistance
- Dokuz Eylül University Affiliated: Yes
Abstract
Technetium-99m hexakis-2-methoxyisobutylisonitrile (MIBI) and thallium-201 imaging was performed in a patient with metastatic renal cell carcinoma (RCC), which is a well-known tumour type demonstrating P1-glycoprotein (PGP) overexpression, Two scintigraphic patterns - TI(+)/MIBI(-) in primary tumour and TI(+)/MIBI(+) in metastatic tumour - were observed, suggesting high- and low-level PGP expression, respectively, Immunochemical study for PGP revealed strong staining of the primary tumour cells, This case clinically validates the previously suggested relationship between Tc-99m-MIBI uptake and PGP expression.